In humans, myeloid-derived suppressor cells (MDSCs) are broadly classified as either neutrophilic or MO MDSCs, and are phenotypically identified as being CD11b+CD15+CD66b+CD33+CD14− or CD11b+CD15−CD33+CD14+HLA-DR-/low, respectively5,6,7,8. In our previous studies, we observed a ...
Myeloid-derived suppressor cells (MDSCs) are a prominent component of the pro-tumoral response. The phenotype of and mechanisms used by MDSCs is heterogeneous and requires more precise characterization in gastric cancer (GC) patients. Here, we have identified a novel subset of CD45+CD33lowCD11b...